Abstract:β-Alanyl-D-histidine (D-CAR, the enantiomer of the natural dipeptide carnosine) is a selective and potent sequestering agent of reactive carbonyl species (RCS) that is stable against carnosinase, but is poorly absorbed in the gastrointestinal tract. Herein we report a drug discovery approach aimed at increasing the oral bioavailability of D-CAR. In our study we designed, synthesized, and evaluated a series of novel lipophilic D-CAR prodrugs. The considered prodrugs can be divided into two categories: 1) derivatives with both terminal groups modified, in which the carboxyl terminus is always esterified while the amino terminus is protected by an amidic (N-acetyl derivatives) or a carbamate (ethyloxy or benzyloxy derivatives) function; 2) derivatives with only one terminus modified, which can be alkyl esters as well as amidic or carbamate derivatives. The prodrugs were designed considering their expected lipophilicity and their hydrolysis predicted by docking simulations on the most important human carboxylesterase (hCES1). The stability and metabolic profile of the prodrugs were studied by incubating them with rat and human serum and liver fractions. The octyl ester of D-CAR (compound 13) was chosen as a candidate for further pharmacological studies due to its rapid hydrolysis to the bioactive metabolite in vitro. Pharmacokinetic studies in rats confirmed the in vitro data and demonstrated that the oral bioavailability of D-CAR is increased 2.6-fold if given as an octyl ester relative to D-CAR. Compound 13 was then found to dose-dependently (at daily doses of 3 and 30 mg kg(-1) equivalent of D-CAR) decrease the development of hypertension and dyslipidemia, to restore renal functions of Zucker fa/fa obese rats, and to inhibit the carbonylation process (AGEs and pentosidine) as well as oxidative stress (urinary 8-epi-prostaglandin F2α and nitrotyrosine). A plausible mechanism underlying the protective effects of 13 is RCS sequestration, as evidenced by the significant increase in the level of adduct between CAR and 4-hydroxy-trans-2-nonenal (HNE, the main RCS generated by lipid oxidation) in the urine of treated animals.

Carbazate modified dextrans as scavengers for carbonylated proteins

Dextran-based thermo-responsive hemoglobin–polymer conjugates with oxygen-carrying capacity

Carbazate functionalized cellulose beads as potential scavengers specific for carbonylated proteins

Synthesis and Characterization of Azo-Containing Dextran Hydrogels as Carriers for Colonic Drug Targeting

Enzyme‐based Hydrogels Containing Dextran As Drug Delivery Carriers: Preparation, Characterization, and Protein Release

Weakly acidic carboxy group-grafted β-cyclodextrin-threaded acid-degradable polyrotaxanes for modulating protein interaction and cellular internalization

Characterization of Dextran Biosynthesized by Glucansucrase from Leuconostoc pseudomesenteroides and Their Potential Biotechnological Applications

Cografting of Zwitterionic Sulfobetaines and Cationic Amines on β-Cyclodextrin-Threaded Polyrotaxanes Facilitates Cellular Association and Tissue Accumulation with High Biocompatibility

Multifunctional Oxidized Dextran as a Matrix for Stabilization of Octahedral Molybdenum and Tungsten Iodide Clusters in Aqueous Media

Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability

In Vitro and in Vivo Investigation of the Novel Dex-bHb As Oxygen Carriers

Ethoxy Acetalated Dextran-Based Biomaterials for Therapeutic Applications

Esterification of dextran by octenyl succinic anhydride (OSA): Physicochemical characterization and functional properties assessment

Mechanism analysis of a novel natural cationic modified dextran flocculant and its application in the treatment of blue algal blooms

Roles of Dextrans on Improving Lymphatic Drainage for Liposomal Drug Delivery System.

Protective Effects of Polysaccharides from Atractylodes Macrocephalae Koidz. Against Dextran Sulfate Sodium Induced Intestinal Mucosal Injury on Mice.

Chemically modified dextrans modulate expression of collagen phenotype by cultured smooth muscle cells in relation to the degree of carboxymethyl, benzylamide, and sulfation substitutions.

Oxidation-Sensitive Dextran-Based Polymer with Improved Processability through Stable Boronic Ester Groups.

One-step Preparation of AIE-active Dextran Via Formation of Phenyl Borate and Their Bioimaging Application

Structural characterization and stability of glycated bovine serum albumin-kaempferol nanocomplexes

Ultrasonic extraction, structural modification and gastric mucosal cells protective activity of a polysaccharide from Dendrobium denneanum